PML AS A MARKER FOR CERVICAL CANCER

PML 作为宫颈癌的标志物

• 批准号: 7365610
• 负责人: VICKIE J LAMORTE
• 金额: $ 0.96万
• 依托单位: UNIVERSITY OF CALIFORNIA-IRVINE
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-04-01 至 2007-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7365610
• 关键词: PML; MARKER; CERVICAL; CANCER

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this project is to examine PML protein in cervical sections by immunohistochemistry and to establish a correlation between the level of protein expression and the degree of dysplasia.

本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者（PI）可能已经从另一个NIH来源获得了主要资金，因此可以在其他CRISP条目中表示。列出的机构是中心的，不一定是研究者的机构。本项目的目的是通过免疫组织化学检测宫颈切片PML蛋白，并建立蛋白表达水平与不典型增生程度之间的相关性。